Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways

31 Jan 2023

Abstract excerpt

Adenoid cystic carcinoma (ACC) of salivary gland is a slowly growing tumor showing a propensity for delayed recurrence, with decreased survival rates. The identification of poor prognosis patients may help in defining molecular-based targeted strategies in this rare disease orphan of new treatments. Through a gene expression microarray-based approach followed by GSE functional analysis the expression profile of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ear and Head Tumors
Share to Salivary Gland Tumors Diagnosis and Treatment
Share to Tumors and Oncological Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36720951
DOI: 10.1038/s41598-023-28901-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathwaysPMID 36720951Read ↗

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.Semantic proximity Read ↗

Extracting potential new targets for treatment of Adenoid Cystic Carcinoma using bioinformatic methodsSemantic proximity Read ↗

Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.Semantic proximity Read ↗

Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomesSemantic proximity Read ↗

Transcriptomic insights into adenoid cystic carcinoma via RNA sequencingSemantic proximity Read ↗

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingSemantic proximity Read ↗

Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments.Semantic proximity Read ↗

MYB-fusions and other potential actionable targets in adenoid cystic carcinoma.Semantic proximity Read ↗

Reversible Downregulation of HLA Class I in Adenoid Cystic CarcinomaSemantic proximity Read ↗

Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Semantic proximity Read ↗

High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinomaSemantic proximity Read ↗

AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.